Well planned and coordinated multi-center phase I and II studies are critical for advancing the field of hematopoietic cell transplantation. To facilitate such studies, the CIBMTR has formed the Resource for Clinical Investigation in Blood and Marrow Transplantation (RCI BMT) to provide statistical expertise and data management services for multi-center phase I/II trials. While not a funding agency, the CIBMTR, through the RCI BMT, will partner with investigators to obtain necessary support for trial completion.
The goal of the RCI BMT is to bridge the gap between single-center studies and the larger phase II and phase III studies conducted by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), also coordinated by the CIBMTR in collaboration with the National Marrow Donor Program and the EMMES Corporation. The focus of the RCI BMT will be to facilitate studies addressing various transplant issues. For example:
- conditioning regimens
- different stem cell sources
- non-interventional transplant-focused trials (e.g. interview studies of long-term survivors)
- novel means of preventing or treating post-transplant complications including relapse of the primary disease
To find out more about the RCI BMT follow this link.